Fairly uncommon, ovarian cancer is daunting because of its poor prognosis. A new study confirms the protective role of oral contraception. The advantage is that even 30 years after stopping the pill, the protection lasts …
1.Against ovarian cancer, gynecologic surveillance is needed
2.One factor that protects against ovarian cancer: oral contraception
Against ovarian cancer, gynecologic surveillance is needed
The poor prognosis of ovarian cancer is related to the fact that it is very long asymptomatic and therefore detected late, a late stage. In this context, prevention is a considerable asset. It is recommended that a very regular gynecological monitoring and consult your doctor or gynecologist if signs suggestive (but not specific for ovarian cancer): swelling or tension of the abdomen, feeling of weight on his stomach, and pelvic pain lumbar, needs to urinate, digestive disorders, weight changes, menstrual irregularities, painful intercourse, fatigue, etc..
Meanwhile, some women are more at risk than others. Indeed, risk factors are well known: age (50 years), family history of ovarian cancer, uterine, breast and colon cancer, genetic predisposition involving the same gene as that associated with breast cancer , early menarche, late menopause, first birth at a late age, not having children, and hormone replacement therapy for menopause .
One factor that protects against ovarian cancer: oral contraception
Long suggested, a new study confirms the role of a protective factor, this time: it is the oral contraceptive. How the pill (heavily used in young women) can it be interesting vis-à-vis a cancer that occurs in most cases after menopause? Is that oral contraception protects against ovarian cancer 30 years after stopping.
Some 20,000 women with ovarian cancer (mean age of cancer diagnosis : 56 years) were compared with 87,000 control women from 21 different countries. It turns out that the longer the duration of oral contraceptive use was longer, the risk of ovarian cancer is decreased. Moreover, if this protective effect tends to diminish over time, it nevertheless persists beyond 30 years after stopping the pill.
When the pill was stopped less than 10 years ago, the risk is reduced by 29%. Stopped for a pill from 10 to 20 years ago, the risk reduction was 19% and is still 15% for women who stopped the pill from 20 to 30 years earlier.
Knowing that hundreds of millions of young women use the pill worldwide, we can expect that the pill would avoid 30,000 ovarian tumors annually in the years to come …